Fc-erythropoietin fusion protein with improved pharmacokinetics
US7465447B2 · kind B2 · utility
19Cited by
88References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 30, 2004 |
| Grant date | Dec 16, 2008 |
| Priority date | — |
| Expiry date | Jan 12, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides Fc-erythropoietin (“Fc-EPO”) fusion proteins with improved pharmacokinetics. Nucleic acids, cells, and methods relating to the production and practice of the invention are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.